William Drobyski

Professor

Medical College of Wisconsin

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Drobyski is a Professor at the Medical College of Wisconsin. His research focuses on immune responses during graft-versus-host disease, viral infections, and the impact of therapies on gastrointestinal health and microbial diversity. His recent work includes studies on T cell differentiation, chronic graft-versus-host disease, and innovative therapeutic approaches in hematopoietic cell transplantation.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Jie Sun

Harrison Distinguished Teaching Professor

University of Virginia

UNITED STATES

View details

Weiguo Cui

UNITED STATES

View details

James Jerkins

Vanderbilt University Medical Center

UNITED STATES

View details

Nita H. Salzman

Medical College of Wisconsin

UNITED STATES

View details

Larry Anderson

Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Alison Moe

Medical College of Wisconsin

UNITED STATES

View details

Anthony Zamora

Assistant Professor

Medical College of Wisconsin

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Drobyski

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation

Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft-versus-host disease

Bhlhe40 Promotes CD4<sup>+</sup> T Helper 1 Cell and Suppresses T Follicular Helper Cell Differentiation during Viral Infection

Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States

Interleukin-9 production by type 2 innate lymphoid cells induces Paneth cell metaplasia and small intestinal remodeling

Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination

Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885, (S1083879120304146), (10.1016/j.bbmt.2020.07.005)]

Single-cell immune profiling reveals a developmentally distinct CD41 GM-CSF1 T-cell lineage that induces GI tract GVHD

The effect of tocilizumab on patient reported outcomes and inflammatory biomarkers in hematopoietic cell transplantation

Budesonide Prophylaxis Reduces the Risk of Engraftment Syndrome After Autologous Hematopoietic Cell Transplantation in Multiple Myeloma

Collaborators (7)

Jie Sun

Weiguo Cui

James Jerkins

Nita H. Salzman

Larry Anderson

Alison Moe

Anthony Zamora

Make your next move.